Future moves could widen this coverage difference, significantly weakening the TFL benefit
The polyethylene glycolylated mouse leptin antagonist (PEG-MLA)-treated mice exhibit increased fasting and glucose stimulated plasma insulin levels, decreased whole-body insulin sensitivity, elevated hepatic glucose production, and impaired insulin-mediated suppression of hepatic glucose production (Levi et al., 2011)
[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Best JH, Lavillotti K, Deyoung MB, Garrison LP
Sarah's 18% vs
To succeed on a failure to warn claim, a plaintiff must prove that the pharmaceutical company failed to provide adequate warnings regarding the drugs risks, that they suffered an injury, and that the failure to warn was the proximate cause of their injury
de la Pea A, Cui X, Geiser J, Loghin C